跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CRIXAN TABLET 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
CRIXAN TABLET 250 MG
Approved
THERAPEUTIC
CRIXAN TABLET 250 MG
RANBAXY MALAYSIA SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
May 25, 2002
Approval ID
cdc0b0f5e2d05d3b
Company
RANBAXY MALAYSIA SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
cdc0b0f5e2d05d3b
Drug Name
CRIXAN TABLET 250 MG
Product Name
CRIXAN TABLET 250 MG
Approval Number
SIN11958P
Approval Date
2002-05-25
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01FA09
Atc Item Name
clarithromycin
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Active Ingredients
CLARITHROMYCIN
250 mg
CLARITHROMYCIN
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 25, 2002
Approval ID
cdc0b0f5e2d05d3b
Type
Therapeutic
Back to HSA Approvals